Document is current
Any future updates will be listed below
-
Authors
Perlstein, Itay
Merenlender Wagner, Avia
Elgart, Anna
Zandvliet, Anthe S.
Hellmann, Farina
Lin, YuWei
van Maanen, Eline
Plock, Nele
Fauchet, Floris
Singh, Rajendra https://orcid.org/0000-0003-2719-4573
-
Funding
Funding for this research was provided by:
Teva Branded Pharmaceutical Products R&D, Inc.
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 24 February 2025
First Online: 23 March 2025
Declarations
:
: This study was supported by funding from Teva Branded Pharmaceutical Products R&D LLC. Itay Perlstein has received consultancy fees from Teva Pharmaceuticals in relation to this study. Avia Merenlender Wagner, Anna Elgart, and Rajendra Singh are employees and/or shareholders of Teva Pharmaceuticals. Anthe Zandvliet, Farina Hellmann, YuWei Lin, Eline van Maanen, Nele Plock, and Floris Fauchet are employees of Certara, which has received payments from Teva Pharmaceuticals in relation to this study.
: This article is based on data from previously conducted studies and does not contain any new studies with human participants. All involved study centers of the original clinical trials received approval by local ethics committees, and informed consent was received for all patients. Consent was obtained during the original clinical trials, and no new consent forms were required/collected for this analysis.
